Dr. Paller presents highlights from recent clinical studies in AD, which highlight the potential benefits of early and effective AD treatment in modifying disease progression and mitigating atopic comorbidities.
Recent research on AD treatment highlights their impact on disease progression and comorbidities. For example, proactive topical treatment of AD in infants was shown to reduce egg allergy. Certain treatments reduce allergies and improve bone density in children with moderate-to-severe AD. Effective early AD treatment may prevent or mitigate atopic comorbidities.
Walter J. Hamlin Professor and Chair of Dermatology; Professor of Pediatrics at Northwestern University, Evanston, Illinois, US
See author’s profile